379 related articles for article (PubMed ID: 11952856)
1. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.
Ueno H; Murphy J; Jass JR; Mochizuki H; Talbot IC
Histopathology; 2002 Feb; 40(2):127-32. PubMed ID: 11952856
[TBL] [Abstract][Full Text] [Related]
2. A new prognostic staging system for rectal cancer.
Ueno H; Price AB; Wilkinson KH; Jass JR; Mochizuki H; Talbot IC
Ann Surg; 2004 Nov; 240(5):832-9. PubMed ID: 15492565
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding as a prognostic marker in stage-III rectal carcinoma.
Choi HJ; Park KJ; Shin JS; Roh MS; Kwon HC; Lee HS
Int J Colorectal Dis; 2007 Aug; 22(8):863-8. PubMed ID: 17216219
[TBL] [Abstract][Full Text] [Related]
4. Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy.
Du C; Xue W; Li J; Cai Y; Gu J
Hum Pathol; 2012 Jul; 43(7):1061-7. PubMed ID: 22204710
[TBL] [Abstract][Full Text] [Related]
5. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
6. Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases.
Sannier A; Lefèvre JH; Panis Y; Cazals-Hatem D; Bedossa P; Guedj N
Histopathology; 2014 Nov; 65(5):623-30. PubMed ID: 24701980
[TBL] [Abstract][Full Text] [Related]
7. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
[TBL] [Abstract][Full Text] [Related]
9. Criteria for extramural perineural invasion as a prognostic factor in rectal cancer.
Ueno H; Hase K; Mochizuki H
Br J Surg; 2001 Jul; 88(7):994-1000. PubMed ID: 11442534
[TBL] [Abstract][Full Text] [Related]
10. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
11. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.
Ueno H; Mochizuki H; Hashiguchi Y; Ishikawa K; Fujimoto H; Shinto E; Hase K
Ann Surg; 2004 Jan; 239(1):34-42. PubMed ID: 14685098
[TBL] [Abstract][Full Text] [Related]
12. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
14. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM
Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic infiltration and survival in rectal cancer.
Jass JR
J Clin Pathol; 1986 Jun; 39(6):585-9. PubMed ID: 3722412
[TBL] [Abstract][Full Text] [Related]
16. Tumour budding as prognostic factor in stage I/II colorectal carcinoma.
Prall F; Nizze H; Barten M
Histopathology; 2005 Jul; 47(1):17-24. PubMed ID: 15982319
[TBL] [Abstract][Full Text] [Related]
17. Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma.
Okuyama T; Oya M; Yamaguchi M
Jpn J Clin Oncol; 2002 Oct; 32(10):412-6. PubMed ID: 12451038
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumor budding in invasive breast cancer.
Liang F; Cao W; Wang Y; Li L; Zhang G; Wang Z
Pathol Res Pract; 2013 May; 209(5):269-75. PubMed ID: 23561623
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer.
Benzoni E; Intersimone D; Terrosu G; Bresadola V; Cojutti A; Cerato F; Avellini C
J Clin Pathol; 2006 May; 59(5):505-12. PubMed ID: 16522747
[TBL] [Abstract][Full Text] [Related]
20. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
